Mitsutaka Nishimoto

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution

Joshua Kellner, Eveline M. Delemarre, Eric Yvon et al. · Oncotarget · 2018 · 41 citations · Full text

HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome

Hirohisa Nakamae, Hideo Koh, Takako Katayama et al. · Experimental Hematology · 2015 · 40 citations

Cell Therapy, Transplantation, Marrow Transplantation +11

Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy

Hiroshi Okamura, Hirohisa Nakamae, Takero Shindo et al. · Frontiers in Immunology · 2021 · 27 citations · Full text

Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia

Mizuki Aimoto, Hideo Koh, Takako Katayama et al. · Infection · 2014 · 26 citations

Antimicrobial Susceptibility, Medicine, Pathogenesis +8

Dasatinib Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation for an Isolated Central Nervous System Blast Crisis in Chronic Myelogenous Leukemia

Mitsutaka Nishimoto, Hirohisa Nakamae, Ki‐Ryang Koh et al. · Acta Haematologica · 2013 · 19 citations

Mixed-phenotype Acute Leukemia, Immunology, Dasatinib Maintenance Therapy +21